An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Johnson & Johnson Innovative Medicine seeks a Senior Scientist, Biostatistics to lead statistical design and analysis for clinical research and development programs. You will drive methodological innovations, support regulatory interactions, and partner with cross‑functional teams to shape trial design and interpretation.
The role emphasizes leadership in study design, proactive problem solving, and collaboration across internal and external partners to advance our therapeutic pipeline.
Role: Senior Scientist, Biostatistics within Johnson & Johnson Innovative Medicine, supporting clinical research, development, and medical programs.
Responsibilities include designing and executing studies using advanced statistical methods, interpreting data, and ensuring regulatory compliance. The role involves collaboration across functions such as QSCP and external partners, with a focus on optimizing trial design, addressing complex project challenges, and contributing to scientific publications.
Qualifications: Ph.D. in Statistics or related field (or Master’s with relevant experience), proficiency in R, SAS, and familiarity with Python, plus excellent communication skills. Experience in pharmaceutical R&D, understanding of disease areas, and knowledge of GxP standards are preferred.
The position emphasizes innovative statistical techniques, cross-functional influence, and leadership in study design and problem-solving. High-value specifics include supporting research in innovative medicine, biologics, or small molecules across various development stages, with a focus on clinical trials and regulatory interactions.
Location: On-site in Spring House PA, Titusville NJ, Raritan NJ, San Diego CA, or Cambridge MA; no remote option.
Travel: Not specified.
The role requires proactive engagement in scientific and methodological advancements, overseeing project quality, and fostering external collaborations to advance Johnson & Johnson’s therapeutic pipeline.